当前位置: X-MOL 学术Biotechnol. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamiana
Biotechnology Journal ( IF 3.2 ) Pub Date : 2021-01-22 , DOI: 10.1002/biot.202000566
Alexandra Castilho 1 , Jennifer Schwestka 1 , Nikolaus F Kienzl 1 , Ulrike Vavra 1 , Clemens Grünwald-Gruber 2 , Shiva Izadi 1, 3 , Chaitra Hiremath 1 , Janine Niederhöfer 4 , Elisabeth Laurent 5 , Vanessa Monteil 6 , Ali Mirazimi 6 , Gerald Wirnsberger 4 , Johannes Stadlmann 2 , Eva Stöger 1 , Lukas Mach 1 , Richard Strasser 1
Affiliation  

Human angiotensin-converting enzyme 2 (ACE2) is the primary host cell receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binding and cell entry. Administration of high concentrations of soluble ACE2 can be utilized as a decoy to block the interaction of the virus with cellular ACE2 receptors and potentially be used as a strategy for treatment or prevention of coronavirus disease 2019. Human ACE2 is heavily glycosylated and its glycans impact on binding to the SARS-CoV-2 spike protein and virus infectivity. Here, we describe the production of a recombinant soluble ACE2-fragment crystallizable (Fc) variant in glycoengineered Nicotiana benthamiana. Our data reveal that the produced dimeric ACE2-Fc variant is glycosylated with mainly complex human-type N-glycans and functional with regard to enzyme activity, affinity to the SARS-CoV-2 receptor-binding domain, and wild-type virus neutralization.

中文翻译:


在糖工程烟草中产生具有酶活性的 SARS-CoV-2 诱饵受体 ACE2-Fc



人血管紧张素转换酶 2 (ACE2) 是严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 结合和进入细胞的主要宿主细胞受体。施用高浓度的可溶性 ACE2 可用作诱饵,阻断病毒与细胞 ACE2 受体的相互作用,并有可能用作治疗或预防 2019 年冠状病毒病的策略。人类 ACE2 高度糖基化,其聚糖对与 SARS-CoV-2 刺突蛋白和病毒感染性的结合。在这里,我们描述了在糖工程烟草中生产重组可溶性 ACE2 片段可结晶 (Fc) 变体。我们的数据显示,产生的二聚体 ACE2-Fc 变体主要与复杂的人型N-聚糖进行糖基化,并在酶活性、对 SARS-CoV-2 受体结合结构域的亲和力以及野生型病毒中和方面具有功能。
更新日期:2021-01-22
down
wechat
bug